1 |
Arroyo V, Moreau R, Jalan R. Acute-on-chronic liver failure[J]. N Engl J Med, 2020, 382(22):2137-2145.
|
2 |
Mahmud N, Kaplan DE, Taddei TH, et al. Incidence and mortality of acute-on-chronic liver failure using two definitions in patients with compensated cirrhosis[J]. Hepatology, 2019, 69(5):2150-2163.
|
3 |
Thuluvath PJ, Thuluvath AJ, Hanish S, et al. Liver transplantation in patients with multiple organ failures: feasibility and outcomes[J]. J Hepatol, 2018, 69(5):1047-1056.
|
4 |
Yoo HY, Thuluvath PJ. The effect of insulin-dependent diabetes mellitus on outcome of liver transplantation[J]. Transplantation, 2002, 74(7):1007-1012.
|
5 |
Moreau R, Jalan R, Gines P, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis[J]. Gastroenterology, 2013, 144(7):1426-1437.
|
6 |
Younossi ZM, Stepanova M, Saab S, et al. The impact of type 2 diabetes and obesity on the long-term outcomes of more than 85 000 liver transplant recipients in the US[J]. Aliment Pharmacol Ther, 2014, 40(6):686-694.
|
7 |
Brodosi L, Petta S, Petroni ML, et al. Management of diabetes in candidates for liver transplantation and in transplant recipients[J]. Transplantation, 2022, 106(3):462-478.
|
8 |
Sundaram V, Jalan R, Shah P, et al. Acute on chronic liver failure from nonalcoholic fatty liver disease: a growing and aging cohort with rising mortality[J]. Hepatology, 2021, 73(5):1932-1944.
|
9 |
Sundaram V, Jalan R, Ahn JC, et al. Class III obesity is a risk factor for the development of acute-on-chronic liver failure in patients with decompensated cirrhosis[J]. J Hepatol, 2018, 69(3):617-625.
|
10 |
Singal AK, Mathurin P. Diagnosis and treatment of alcohol-associated liver disease: a review[J]. JAMA, 2021, 326(2):165-176.
|
11 |
Singal AK, Ahmed Z, Axley P, et al. Hospitalizations for acute on chronic liver failure at academic compared to non-academic centers have higher mortality[J]. Dig Dis Sci, 2021, 66(4):1306-1314.
|
12 |
Gustot T, Jalan R. Acute-on-chronic liver failure in patients with alcohol-related liver disease[J]. J Hepatol, 2019, 70(2):319-327.
|
13 |
Ferguson D, Finck BN. Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus[J]. Nat Rev Endocrinol, 2021, 17(8):484-495.
|
14 |
Axley P, Ahmed Z, Arora S, et al. NASH is the most rapidly growing etiology for acute-on-chronic liver failure-related hospitalization and disease burden in the United States: a population-based study[J]. Liver Transpl, 2019, 25(5):695-705.
|